American Transit Insurance Co. v. Bradley Pierre, Marvin Moy, M.D., Rutland Medical P.C., William A. Weiner, D.O., Nexray Medical Imaging, P.C., d/b/a Soul Radiology Medical Imaging, John Does 1-15
This text of American Transit Insurance Co. v. Bradley Pierre, Marvin Moy, M.D., Rutland Medical P.C., William A. Weiner, D.O., Nexray Medical Imaging, P.C., d/b/a Soul Radiology Medical Imaging, John Does 1-15 (American Transit Insurance Co. v. Bradley Pierre, Marvin Moy, M.D., Rutland Medical P.C., William A. Weiner, D.O., Nexray Medical Imaging, P.C., d/b/a Soul Radiology Medical Imaging, John Does 1-15) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ----------------------------------------------------------X AMERICAN TRANSIT INSURANCE CO.,
Plaintiff,
ORDER -against- 24 CV 360 (SJB) (CLP)
BRADLEY PIERRE, et al.,
Defendants. ----------------------------------------------------------X POLLAK, United States Magistrate Judge:
On January 17, 2024, plaintiff American Transit Insurance (“American Transit” or “plaintiff”) commenced this action against defendants Bradley Pierre (“Pierre”), Marvin Moy, M.D. (“Moy”), Rutland Medical P.C. (“Rutland”), William A. Weiner, D.O. (“Weiner”), Nexray Medical Imaging, P.C., d/b/a Soul Radiology Medical Imaging (“Nexray”), and John Does 1-15. (Compl. ¶ 1). Plaintiff alleges that defendants operated an illegal scheme to defraud plaintiff by collecting payments on non-compensable and fraudulent No-Fault insurance claims, and it asserts claims under the Racketeer Influenced and Corrupt Organizations Act, 18 U.S.C. §§ 1961 et seq., the Declaratory Judgment Act, 28 U.S.C. §§ 2201, 2202, and New York Public Health Law § 238(a). (Id.) Presently before the Court is plaintiff’s motion to compel document production pursuant to a subpoena duces tecum served upon defendant Pierre’s wholly-owned company, non-party Marketing 4 You, Inc. (“M4Y”). (Mot.1)
PROCEDURAL BACKGROUND Plaintiff filed the Complaint on January 17, 2024. (ECF No. 1). On April 9, 2024,
1 References to “Mot.” refer to plaintiff’s motion to compel filed on April 24, 2025 (ECF No. 167). plaintiff moved for default judgment against defendant Pierre (ECF No. 37), and the Court ordered that Pierre “either arrange with plaintiff to pay [the] costs of [a] default judgment motion or file [a] motion to vacate.” (Minute entry, dated June 13, 2024). On July 26, 2024, Pierre moved to vacate the default (ECF No. 73), and on August 27, 2024, this Court recommended that
the district court grant the motion to vacate default on the condition that Pierre pay a reasonable portion of plaintiff’s attorney’s fees. (ECF No. 77). The district court adopted the Report and Recommendation on March 19, 2025. (ECF No. 153). This Court submitted a Report and Recommendation on the amount of the fee award on August 25, 2025, recommending that the district court order the payment due by September 9, 2025 (ECF No. 187), and on September 10, 2025, the Court recommended that the district court enter default judgment against defendant Pierre as to liability for his failure to pay the recommended attorney’s fees. (ECF No. 193). While the question of Pierre’s default status was pending, on February 11, 2025, plaintiff served a subpoena duces tecum on M4Y, a nonparty company wholly owned by Pierre, with a response deadline of March 31, 2025. (Mot. at 1). M4Y never responded and, on April 24,
2025, plaintiff filed the present motion to compel. (Id.). The motion is unopposed.
DISCUSSION “Motions to compel and motions to quash a subpoena are entrusted to the sound discretion of the district court.” In re Fitch, Inc., 330 F.3d 104, 108 (2d Cir. 2003) (quoting United States v. Sanders, 211 F.3d 711, 720 (2d Cir. 2000)); Ehrlich v. Incorporated Vill. of Sea Cliff, No. 04 CV 4025, 2007 WL 1593211, at *2 (E.D.N.Y. May 31, 2007). A trial court’s rulings with regard to discovery “are reversed only upon a clear showing of an abuse of discretion.” Id., at *2 (quoting In re DG Acquisition Corp., 151 F.3d 75, 79 (2d Cir. 1998)). The party moving to quash a subpoena has the burden of establishing “that the information that is the subject of the subpoena is not discoverable.” de Venustas v. Venustas Int'l, LLC, No. 07 CV 4530, 2008 WL 619028, at *2 (S.D.N.Y. Mar. 5, 2008) (citing Concord Boat Corp. v. Brunswick Corp., 169 F.R.D. 44, 48 (S.D.N.Y. 1996)). Moreover, a party generally lacks standing to quash or modify a subpoena directed to a non-party unless he is seeking to protect a personal privilege
or right. Allstate Ins. Co. v. Zelefsky, No. 13 CV 5830, 2014 WL 12661264, at *1 (E.D.N.Y. Mar. 7, 2014). Federal Rule of Civil Procedure 26(b)(1) governs the scope of discovery in federal court cases. Rule 26(b)(1) “authorizes discovery of any ‘nonprivileged matter that is relevant to any party’s claim or defense.... Relevant information need not be admissible at the trial if the discovery appears reasonably calculated to lead to the discovery of admissible evidence.’ ” Garcia v. Benjamin Grp. Ent. Inc., 800 F.Supp.2d 399, 403 (E.D.N.Y. 2011) (quoting Fed. R. Civ. P. 26(b)(1)). “ ‘Relevance’ under Rule 26 ‘has been construed broadly to encompass any matter that bears on, or that reasonably could lead to other matter that could bear on any issue that is or may be in the case.’ ” Crosby v. City of New York, 269 F.R.D. 267, 282 (S.D.N.Y.
2010) (quoting Oppenheimer Fund, Inc. v. Sanders, 437 U.S. 340, 351, 98 S.Ct. 2380, 57 L.Ed.2d 253 (1978)). While the scope of discovery is “broad,” it is not “limitless.” Fears v. Wilhelmina Model Agency, Inc., No. 02 CV 4911, 2004 WL 719185, at *1 (S.D.N.Y. Apr. 1, 2004). Further, as specified in the amended Rule 26, discovery must be “proportional to the needs of the case.” Fed. R. Civ. P. 26(b)(1). Thus, Rule 26(b)(2)(c) requires the Court to limit the extent of discovery where “the discovery sought is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive” or “the burden or expense of the proposed discovery outweighs its likely benefit.” Indeed, subpoenas under Rule 45 are not intended to provide an “end-run around the regular discovery process under Rules 26 and 34.” Burns v. Bank of Am., No. 03 CV 1685, 2007 WL 1589437, at *14 (S.D.N.Y. June 4, 2007). “If documents are available from a party, it has been thought preferable to have them obtained pursuant to Rule 34 rather than subpoenaing them from a non-party witness pursuant to Rule
45.” Id. (citation omitted). Plaintiff states that the discovery is relevant because M4Y is a central witness to the facts in this case. (Mot. at 2). Indeed, defendant Pierre testified during his criminal plea allocution that he “utilized two companies in connection with the healthcare fraud and bribery schemes: Medical Reimbursement Consultants…and Marketing 4 You or ‘M4Y.’” United States of America v. Bradley Pierre, No. 22 CR 19, ECF No. 344 at 25:7-17 (S.D.N.Y. Jan. 8, 2024). He also acknowledged using “phony loan agreements” to control clinics. Id. at 22:12-10. Further, Pierre told Judge Gardephe that he did not dispute any of these facts. (Id. at 20:12-25:15 (Q. “Do you dispute anything that I just read?” A. “No, your Honor”)). Given defendant Pierre’s own statements and his failure to provide any documents
through the regular party discovery process, the Court finds that the documents sought from M4Y are highly relevant and proportional to the needs of the case.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
American Transit Insurance Co. v. Bradley Pierre, Marvin Moy, M.D., Rutland Medical P.C., William A. Weiner, D.O., Nexray Medical Imaging, P.C., d/b/a Soul Radiology Medical Imaging, John Does 1-15, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-transit-insurance-co-v-bradley-pierre-marvin-moy-md-rutland-nyed-2025.